Commonwealth Diagnostics International Inc v. Newtek Small Business Finance LLC

CourtDistrict Court, D. Massachusetts
DecidedMarch 8, 2023
Docket1:22-cv-10747
StatusUnknown

This text of Commonwealth Diagnostics International Inc v. Newtek Small Business Finance LLC (Commonwealth Diagnostics International Inc v. Newtek Small Business Finance LLC) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Commonwealth Diagnostics International Inc v. Newtek Small Business Finance LLC, (D. Mass. 2023).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS

CIVIL ACTION NO. 22-10747-RGS

COMMONWEALTH DIAGNOSTICS INTERNATIONAL INC.

v.

NEWTEK SMALL BUSINESS FINANCE LLC

MEMORANDUM AND ORDER ON PLAINTIFF’S MOTION FOR PRELIMINARY INJUNCTION

March 8, 2023

STEARNS, D.J. Commonwealth Diagnostics International, Inc. (CDI), a clinical diagnostics and health technology startup company, brought this suit against its lender, Newtek Small Business Finance, LLC (Newtek), under common- law theories of fraudulent inducement and recission and for violation of Mass. Gen. Laws ch. 93A prohibiting unfair and deceptive acts. CDI alleges that Newtek, in providing a $5 million loan, misrepresented that the Small Business Administration (SBA) required collateral largely exceeding the loan amount and overcollateralized the loan. CDI also alleges that the COVID-19 pandemic rendered performance of its loan agreement with Newtek impossible. CDI now moves for a preliminary injunction to prevent Newtek from liquidating CDI’s collateral for a period of at least six months.

BACKGROUND CDI’s main business is the manufacture and analysis of diagnostic tests for gastrointestinal illnesses. CDI formed in 2015 and began operating in 2017. In mid-2017, seeking financing to reintroduce several products its

principals, Brian Strasnick and Craig Strasnick, had previously developed, CDI sought a $5 million loan from Newtek, an SBA-approved lender. The loan closed in September of 2017.

Newtek required over $9 million in collateral for the loan to CDI, including a Raymond James Collateralized Securities Account (holding approximately $2 million), mortgages on real estate owned by CDI’s affiliate Common Ground Enterprises, LLC (worth about $2 million), and mortgages

on Brian Strasnick’s primary residence and Craig Strasnick’s secondary residence (in combination, worth over $5 million). Second Am. Compl. [Dkt # 42] ¶ 39. Newtek also required personal guaranties from Brian, Craig, and Bonnie (Brian’s wife) Strasnick and from CDI’s affiliates and entities

controlled by the Strasnicks. Id. ¶ 40. CDI took issue with the amount of collateral needed but agreed to the terms of the loan agreement because Newtek told CDI that the amount of collateral had been determined by SBA guidelines. Id. ¶¶ 44-45.

In early 2018, CDI was not as profitable as it had hoped it would be. Consequently, it sought to liquidate some of the property listed as collateral to stay current on its loan payments. Id. ¶¶ 51-52. CDI claims that Newtek required payment of $500,000 from the sale in exchange for release of the

collateral. Id. ¶¶ 53-54. In 2018, CDI began missing loan payments. Id. ¶¶ 57-58; see also Opp. Mot. for Prelim. Inj. [Dkt # 12] ¶¶ 6-7 (noting that Newtek sent two past due loan letters to CDI by August 31, 2018 and

permitted CDI to modify its loan three times). In March of 2020, the COVID-19 pandemic impacted CDI’s income. The number of diagnostic tests it processed decreased significantly; CDI’s overhead increased because materials became more expensive and

personnel costs rose; insurance carriers — which remit payment for CDI’s analysis of the diagnostic test kits — took longer than they had before the pandemic; and CDI also delayed collection on patient payments, wrote off certain tests, and offered hardship-based patient payment plans. CDI was

unable to service the loan under the circumstances. In February of 2022, Newtek declared a default on CDI’s loan and exercised its rights to accelerate the Note, requiring about $4 million immediately. In May of 2022, Newtek announced that it would begin liquidating CDI’s collateral. Id. ¶ 68.

This court stayed this proceeding in June of 2022 pending the Massachusetts Supreme Judicial Court’s (SJC) decision in Le Fort Enterprises, Inc. v. Lantern 18, LLC, 491 Mass. 144 (Jan. 3, 2023), which concerned a similar claim to CDI’s. See 6/14/2022 Order [Dkt # 14]. The

parties were ordered not to take any action in derogation of the status quo until the preliminary injunction motion was resolved. Id. On February 28, 2023, plaintiffs alerted the court that Brian Strasnick

intended to sell his personal residence, which had been pledged as collateral to secure the loan. CDI proposed that the sale be permitted to go forward and the proceeds be placed into an escrow account pending the outcome of this litigation. See Emergency Mot. for Clarification [Dkt # 44] ¶¶ 3-6.

DISCUSSION Courts consider the following when determining whether to award a preliminary injunction: “(1) the movant’s likelihood of success on the merits, (2) the potential for irreparable harm, (3) a balancing of the relevant equities,

and (4) the effect on the public interest.” Campbell Soup Co. v. Giles, 47 F.3d 467, 470 (1st Cir. 1995); Ryan v. U.S. Immig. & Customs Enf’t, 974 F.3d 9, 18 (1st Cir. 2020). “Likelihood of success is the main bearing wall of the four- factor framework.” Ross-Simons of Warwick, Inc. v. Baccarat, Inc., 102 F.3d 12, 16 (1st Cir. 1996); see also CVS Pharmacy, Inc. v. Lavin, 2020 WL

966544, at *3 (1st Cir. Feb. 28, 2020) (Likelihood of success on the merits is the factor that “weighs most heavily in the preliminary injunction analysis.”); Ryan, 974 F.3d at 20 (“If the movant ‘cannot demonstrate that he is likely to succeed in his quest, the remaining factors become matters of idle

curiosity.’”), quoting New Comm Wireless Servs. Inc. v. SprintCom, Inc., 287 F.3d 1, 9 (1st Cir. 2002). The court will address CDI’s likelihood of success on the merits. CDI

makes three arguments. First, CDI argues that the COVID-19 pandemic rendered performance of the loan agreement impracticable. However, considering the SJC’s decision in Le Fort, the court is unconvinced that CDI is likely to prevail

under this theory. As the SJC explained, a plaintiff must establish three elements to establish a claim of impracticability: First, a supervening, extreme event caused the party’s performance to be impracticable. . . . Second “the nonoccurrence of the event was a basic assumption on which the contract was made,” and the occurrence of the event was not a risk that the parties were tacitly assigning to the promisor by their failure to provide for it explicitly . . . . Third, “the impracticability resulted without the fault of the party seeking to be excused.” Le Fort at 153-154 (citations omitted). In Le Fort, the SJC found the “absence of a causal link [between the

pandemic and the co-obligers’ inability to perform] fatal to the co-obliger’s claim of impracticability.” Id. at 155. Here, CDI could met its obligations under the loan agreement. Because the loan was collateralized by an amount at least equal to the loan itself, CDI could perform its obligations under the

loan agreement with Newtek by liquidating its collateral. Its claim of impracticability thus is likely to fail.1 See id. at 156 (“The contract promised repayment -- not repayment from franchise revenue specifically -- and even

if payment from the franchise revenue was made impracticable by the pandemic, the promise to repay was not.”). Additionally, CDI was unable to make its monthly loan payments as early as 2018, which undermines CDI’s claim that the COVID-19 pandemic caused its inability to meet its loan

obligations. Second, CDI argues that Newtek failed to perfect its security interest in Brian Strasnick’s Raymond James Security Account. But the plain language of the Raymond James agreement CDI cites makes it clear that Newtek’s

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Campbell Soup Co. v. Giles
47 F.3d 467 (First Circuit, 1995)
Kenda Corp. v. Pot O'Gold Money Leagues, Inc.
329 F.3d 216 (First Circuit, 2003)
Naser Jewelers, Inc. v. City of Concord, NH
513 F.3d 27 (First Circuit, 2008)
Ross-Simons of Warwick, Inc. v. Baccarat, Inc.
102 F.3d 12 (First Circuit, 1996)

Cite This Page — Counsel Stack

Bluebook (online)
Commonwealth Diagnostics International Inc v. Newtek Small Business Finance LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/commonwealth-diagnostics-international-inc-v-newtek-small-business-finance-mad-2023.